Animal models and the molecular biology of hepadnavirus infection

Cold Spring Harbor Perspectives in Medicine

Volumn 5, Issue 4, 2015, Pages

  Mason, William S ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CIRCULAR DNA; VIRUS PROTEIN; VIRUS DNA;

ANIMAL MODEL; ANTIVIRAL THERAPY; ARTICLE; BLOOD SAMPLING; DNA SYNTHESIS; DUCK; HEPADNAVIRUS INFECTION; HEPATITIS B; HEPATITIS B VIRUS; IMMUNE RESPONSE; LIFE CYCLE; LIVER BIOPSY; LIVER CELL CARCINOMA; MOLECULAR BIOLOGY; NONHUMAN; PATHOGENESIS; PHYLOGENY; REVERSE TRANSCRIPTION; SCIURIDAE; VIRUS DETECTION; VIRUS GENOME; VIRUS INFECTION; VIRUS REPLICATION; WOODCHUCK; ANIMAL; BIOSYNTHESIS; CHRONIC HEPATITIS B; CLASSIFICATION; DISEASE MODEL; DUCK HEPATITIS B VIRUS; GENETICS; HEPADNAVIRIDAE; HUMAN; LIVER TUMOR; ORTHOHEPADNAVIRUS; PHYSIOLOGY; VIROLOGY;

ANAS; ANIMALIA; HEPADNAVIRIDAE; HEPATITIS B VIRUS; HYLOBATIDAE; MACACA; MACACA FASCICULARIS; MARMOTA MONAX; PAN; SPERMOPHILUS; TUPAIA BELANGERI; TUPAIIDAE;

ANIMALS; DISEASE MODELS, ANIMAL; DNA, VIRAL; GENOME, VIRAL; HEPADNAVIRIDAE; HEPADNAVIRIDAE INFECTIONS; HEPATITIS B VIRUS, DUCK; HEPATITIS B, CHRONIC; HUMANS; LIVER NEOPLASMS; ORTHOHEPADNAVIRUS;

EID: 84923810260     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a021352     Document Type: Article

References (146)

1. Aden DP, Fogel A, Plotkin S, Damjanov I, Knowles BB. 1979. Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature 282: 615–616.
2. Alison MR, Islam S, Lim S. 2009. Stem cells in liver regeneration, fibrosis and cancer: The good, the bad and the ugly. J Pathol 217: 282–298.
3. Bartenschlager R, Schaller H. 1988. The amino-terminal domain of the hepadnaviral P-gene encodes the terminal protein (genome-linked protein) believed to prime reverse transcription. EMBO J 7: 4185–4192.
4. Bayer ME, Blumberg BS, Werner B. 1968. Particles associated with Australia antigen in the sera of patients with leukaemia, Down’s syndrome and hepatitis. Nature 218: 1057–1059.
5. Beasley RP, Lin CC, Hwang LY, Chien CS. 1981. Hepatocellular carcinoma and hepatitis B virus. Lancet 2: 1129– 1133.
6. Blum HE, Haase AT, Harris JD, Walker D, Vyas GN. 1984. Asymmetric replication of hepatitis B virus DNA in human liver: Demonstration of cytoplasmic minus strand DNA by blot analysis and in situ hybridization. Virology 139: 87–96.
7. Blumberg BS. 1977. Australia antigen and the biology of hepatitis B. Science 197: 17–25.
8. Blumberg BS, Gerstley BJS, Hungerford DA, London WT, Sutnik AI. 1967. A serum antigen (Australia antigen) in Down’s syndrome, leukemia and hepatitis. Ann Intern Med 66: 924–931.
9. Blumberg BS, Sutnick AI, London WT. 1968. Hepatitis and leukemia: Their relation to Australia antigen. Bull NY Acad Med 44: 1566–1586.
10. Blumberg BS, Larouze B, London WT, Werner B, Hesser JE, Millman I, Saimot G, Payet M. 1975. The relation of infection with the hepatitis B agent to primary hepatic carcinoma. Am J Pathol 81: 669–682.
11. Bruni R, Conti I, Villano U, Giuseppetti R, Palmieri G, Rapicetta M. 2006. Lack of WHV integration nearby Nmyc2 and in the downstream b3n and win loci in a considerable fraction of liver tumors with activated N-myc2 from naturally infected wild woodchucks. Virology 345: 258–269.
12. Buendia M-A, Neuveut C. 2015. Hepatocellular carcinoma. Cold Spring Harb Perspect Med 5: a021444.
13. Burrell CJ, Gowans EJ, Jilbert AR, Lake JR, Marmion BP. 1982. Hepatitis B virus DNA detection by in situ cytohybridization: Implications for viral replication strategy and pathogenesis of chronic hepatitis. Hepatology 2: 85S– 91S.
14. Buscher M, Reiser W, Will H, Schaller H. 1985. Transcripts and the putative RNA pregenome of duck hepatitis B virus: Implications for reverse transcription. Cell 40: 717–724.
15. Campagna MR, Liu F, Mao R, Mills C, Cai D, Guo F, Zhao X, Ye H, Cuconati A, Guo H, et al. 2013. Sulfamoylbenzamide derivatives inhibit the assembly of hepatitis B virus nucleocapsids. J Virol 87: 6931–6942.
16. Challberg MD, Ostrove JM, Kelly TJ. 1982. Initiation of adenovirus DNA replication: Detection of covalent complexes between nucleotide and the 80-kilodalton terminal protein. J Virol 41: 265–270.
17. Chang C, Enders G, Sprengel R, Peters N, Varmus HE, Ganem D. 1987. Expression of the precore region of an avian hepatitis B virus is not required for viral replication. J Virol 61: 3322–3325.
18. Chen HS, Kew MC, Hornbuckle WE, Tennant BC, Cote PJ, Gerin JL, Purcell RH, Miller RH. 1992. The precore gene of the woodchuck hepatitis virus genome is not essential for viral replication in the natural host. J Virol 66: 5682– 5684.
19. Chen HS, Kaneko S, Girones R, Anderson RW, Hornbuckle WE, Tennant BC, Cote PJ, Gerin JL, Purcell RH, Miller RH. 1993. The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks. J Virol 67: 1218–1226.
20. Chisari FV, Klopchin K, Moriyama T, Pasquinelli C, Dunsford HA, Sell S, Pinkert CA, Brinster RL, Palmiter RD. 1989. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 59: 1145– 1156.
21. Condreay LD, Aldrich CE, Coates L, Mason WS, Wu TT. 1990. Efficient duck hepatitis B virus production by an avian liver tumor cell line. J Virol 64: 3249–3258.
22. Cova L, Lambert V, Chevallier A, Hantz O, Fourel I, Jacquet C, Pichoud C, Boulay J, Chomel B, Vitvitski L, et al. 1986. Evidence for the presence of duck hepatitis B virus in wild migrating ducks. J Gen Virol 67: 537–547.
23. Dane DS, Cameron CH, Briggs M. 1970. Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. Lancet 1: 695–698.
24. Drexler JF, Geipel A, Konig A, Corman VM, van Riel D, Leijten LM, Bremer CM, Rasche A, Cottontail VM, Maganga GD, et al. 2013. Bats carry pathogenic hepadnaviruses antigenically related to hepatitis B virus and capable of infecting human hepatocytes. Proc Natl Acad Sci 110: 16151–16156.
25. Fauquet CM, Maniloff J, Desselberger U, Ball LA, eds2005. Virus taxonomy: VIIIth report of the international committee of taxonomy of viruses, pp. 373–384. Academic, San Diego, CA.
26. Fourel G, Trepo C, Bougueleret L, Henglein B, Ponzetto A, Tiollais P, Buendia MA. 1990. Frequent activation of Nmyc genes by hepadnavirus insertion in woodchuck liver tumours. Nature 347: 294–298.
27. Fourel G, Couturier J, Wei Y, Apiou F, Tiollais P, Buendia MA. 1994. Evidence for long-range oncogene activation by hepadnavirus insertion. EMBO J 13: 2526–2534.
28. Fourel I, Cullen JM, Saputelli J, Aldrich CE, Schaffer P, Averett DR, Pugh J, Mason WS. 1994. Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducks. J Virol 68: 8321–8330.
29. Fowler MJ, Monjardino J, Tsiquaye KN, Zuckerman AJ, Thomas HC. 1984. The mechanism of replication of hepatitis B virus: Evidence of asymmetric replication of the two DNA strands. J Med Virol 13: 83–91.
30. Frelin L, Wahlstrom T, Tucker AE, Jones J, Hughes J, Lee BO, Billaud JN, Peters C, Whitacre D, Peterson D, et al. 2009. A mechanism to explain the selection of the hepatitis e antigen-negative mutant during chronic hepatitis B virus infection. J Virol 83: 1379–1392.
31. 0 terminus of its complete DNA strand. Cell 21: 801–809.
32. Gilboa E, Mitra SW, Goff S, Baltimore D. 1979. A detailed model of reverse transcription and tests of crucial aspects. Cell 18: 93–100.
33. Gong SS, Jensen AD, Wang H, Rogler CE. 1995. Duck hepatitis B virus integrations in LMH chicken hepatoma cells: Identification and characterization of new episomally derived integrations. J Virol 69: 8102–8108.
34. Gong SS, Jensen AD, Chang CJ, Rogler CE. 1999. Doublestranded linear duck hepatitis B virus (DHBV) stably integrates at a higher frequency than wild-type DHBV in LMH chicken hepatoma cells. J Virol 73: 1492–1502.
35. Guidotti LG, Chisari FV. 1999. Cytokine-induced viral purging—Role in viral pathogenesis. Curr Opin Microbiol 2: 388–391.
36. Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, Chisari FV. 1999. Viral clearance without destruction of infected cells during acute HBV infection. Science 284: 825–829.
37. Guo JT, Aldrich CE, Mason WS, Pugh JC. 1996. Characterization of serum amyloid A protein mRNA expression and secondary amyloidosis in the domestic duck. Proc Natl Acad Sci 93: 14548–14553.
38. Guo H, Mason WS, Aldrich CE, Saputelli JR, Miller DS, Jilbert AR, Newbold JE. 2005. Identification and classification of avihepadnaviruses isolated from exotic anseriformes maintained in captivity. J Virol 79: 2729–2742.
39. Gurgo C, Ray RK, Thiry L, Green M. 1971. Inhibitors of the RNA and DNA dependent polymerase activities of RNA tumour viruses. Nat New Biol 229: 111–114.
40. Hansen LJ, Tennant BC, Seeger C, Ganem D. 1993. Differential activation of myc gene family members in hepatic carcinogenesis by closely related hepatitis B viruses. Mol Cell Biol 13: 659–667.
41. Hayward WS, Neel BG, Astrin SM. 1981. Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis. Nature 290: 475–480.
42. Heermann KH, Goldmann U, Schwartz W, Seyffarth T, Baumgarten H, Gerlich WH. 1984. Large surface proteins of hepatitis B virus containing the pre-s sequence. J Virol 52: 396–402.
43. Hirota K, Sherker AH, Omata M, Yokosuka O, Okuda K. 1986. Effects of adenine arabinoside and corticosteroid on replication of duck hepatitis B virus DNA in the liver. Ann Acad Med Singapore 15: 227–232.
44. Hu J, Seeger C. 2015. Hepadnavirus genome replication and persistence. Cold Spring Harb Perspect Med doi: 10.1101/ cshperspect.a021386.
45. Iannacone M, Guidotti LG. 2015. Mouse models of hepatitis B virus pathogenesis. Cold Spring Harb Perspect Med doi: 10.1101/cshperspect.a021477.
46. Ikeda JE, Enomoto T, Hurwitz J. 1982. Adenovirus proteinprimed initiation of DNA chains in vitro. Proc Natl Acad Sci 79: 2442–2446.
47. Jilbert AR, Wu TT, England JM, Hall PM, Carp NZ, O’Connell AP, Mason WS. 1992. Rapid resolution of duck hep atitis B virus infections occurs after massive hepatocellular involvement. J Virol 66: 1377–1388.
48. Kajino K, Jilbert AR, Saputelli J, Aldrich CE, Cullen J, Mason WS. 1994. Woodchuck hepatitis virus infections: Very rapid recovery after a prolonged viremia and infection of virtually every hepatocyte. J Virol 68: 5792–5803.
49. Kaplan PM, Greenman RL, Gerin JL, Purcell RH, Robinson WS. 1973. DNA polymerase associated with human hepatitis B antigen. J Virol 12: 995–1005.
50. Kawaguchi T, Nomura K, Hirayama Y, Kitagawa T. 1987. Establishment and characterization of a chicken hepatocellular carcinoma cell line, LMH. Cancer Res 47: 4460– 4464.
51. Khudyakov YE, Makhov AM. 1989. Prediction of terminal protein and ribonuclease H domains in the gene P product of hepadnaviruses. FEBS Lett 243: 115–118.
52. Korba BE, Cote PJ, Menne S, Toshkov I, Baldwin BH, Wells FV, Tennant BC, Gerin JL. 2004. Clevudine therapy with vaccine inhibits progression of chronic hepatitis and delays onset of hepatocellular carcinoma in chronic woodchuck hepatitis virus infection. Antivir Ther 9: 937–952.
53. Lanford RE, Chavez D, Brasky KM, Burns RB III, Rico Hesse R. 1998. Isolation of a hepadnavirus from the woolly monkey, a New World primate. Proc Natl Acad Sci 95: 5757–5761.
54. Lee HJ, Eun R, Jang BI, Kim TN. 2007. Prevention by lamivudine of hepatocellular carcinoma in patients infected with hepatitis B virus. Gut Liver 1: 151–158.
55. Lenhoff RJ, Summers J. 1994. Construction of avian hepadnavirus variants with enhanced replication and cytopathicity in primary hepatocytes. J Virol 68: 5706–5713.
56. Lien JM, Aldrich CE, Mason WS.1986.Evidence that acapped oligoribonucleotide is the primer for duck hepatitis B virus plus-strand DNA synthesis. JViro l57: 229–236.
57. Lien JM, Petcu DJ, Aldrich CE, Mason WS. 1987. Initiation and termination of duck hepatitis B virus DNA synthesis during virus maturation. J Virol 61: 3832–3840.
58. Loeb DD, Hirsch RC, Ganem D. 1991. Sequence-independent RNA cleavages generate the primers for plus strand DNA synthesis in hepatitis B viruses: Implications for other reverse transcribing elements. EMBO J 10: 3533–3540.
59. Lucifora J, Xia Y, Reisinger F, Zhang K, Stadler D, Cheng X, Sprinzl MF, Koppensteiner H, Makowska Z, Volz T, et al. 2014. Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA. Science 343: 1221–1228.
60. Lutgehetmann M, Volz T, Kopke A, Broja T, Tigges E, Lohse AW, Fuchs E, Murray JM, Petersen J, Dandri M. 2010. In vivo proliferation of hepadnavirus-infected hepatocytes induces loss of covalently closed circular DNA in mice. Hepatology 52: 16–24.
61. Madden CR, Finegold MJ, Slagle BL. 2001. Hepatitis B virus X protein acts as a tumor promoter in development of diethylnitrosamine-induced preneoplastic lesions. J Virol 75: 3851–3858.
62. Mandart E, Kay A, Galibert F. 1984. Nucleotide sequence of a cloned duck hepatitis B virus genome: Comparison with woodchuck and human hepatitis B virus sequences. J Virol 49: 782–792.
63. Marion PL, Oshiro LS, Regnery DC, Scullard GH, Robinson WS. 1980. A virus in Beechey ground squirrels that is related to hepatitis B virus of humans. Proc Natl Acad Sci 77: 2941–2945.
64. Marion PL, Van DM, Knight SS, Salazar FH, Garcia G, Popper H, Robinson WS. 1986. Hepatocellular carcinoma in ground squirrels persistently infected with ground squirrel hepatitis virus. Proc Natl Acad Sci 83: 4543–4546.
65. Marongiu F, Doratiotto S, Montisci S, Pani P, Laconi E. 2008. Liver repopulation and carcinogenesis: Two sides of the same coin? Am J Pathol 172: 857–864.
66. Mason WS, Seal G, Summers J. 1980. Virus of Pekin ducks with structural and biological relatedness to human hepatitis B virus. J Virol 36: 829–836.
67. Mason WS, Aldrich C, Summers J, Taylor JM. 1982. Asymmetric replication of duck hepatitis B virus DNA in liver cells: Free minus-strand DNA. Proc Natl Acad Sci 79: 3997–4001.
68. Mason WS, Halpern MS, England JM, Seal G, Egan J, Coates L, Aldrich C, Summers J. 1983. Experimental transmission of duck hepatitis B virus. Virology 131: 375–384.
69. Mason WS, Lien J, Petcu DJ, Coates L, London WT, O’Connell A, Aldrich C, Custer RP. 1987. In vivo and in vitro studies on duck hepatitis B virus replication. In Hepadna viruses (ed. Robinson WS, et al.), pp. 3–16. Alan R. Liss, New York.
70. Mason WS, Xu C, Low HC, Saputelli J, Aldrich CE, Scougall C, Grosse A, Colonno R, Litwin S, Jilbert AR. 2009. The amount of hepatocyte turnover that occurred during resolution of transient hepadnavirus infections was lower when virus replication was inhibited with entecavir. J Virol 83: 1778–1789.
71. Mason WS, Low HC, Xu C, Aldrich CE, Scougall CA, Grosse A, Cloustou A, Chavez D, Litwin S, Peri S, et al. 2009. Detection of clonally expanded heptocytes in chimpanzees with chronic hepatitis B virus infection. J Virol 83: 8396–8408.
72. Meier P, Scougall CA, Will H, Burrell CJ, Jilbert AR. 2003. A duck hepatitis B virus strain with a knockout mutation in the putative X ORF shows similar infectivity and in vivo growth characteristics to wild-type virus. Virology 317: 291–298.
73. Milich DR, Jones J, Hughes J, Maruyama T. 1993. Role of T cell tolerance in the persistence of hepatitis B virus infection.J Immunother Emphasis Tumor Immunol 14:226–233.
74. Millman I, Loeb LA, Bayer ME, Blumberg BS. 1970. Australia antigen (a hepatitis-associated antigen): Purification and physical properties. J Exp Med 131: 1190–1199.
75. Molnar-Kimber KL, Summers J, Taylor JM, Mason WS. 1983. Protein covalently bound to minus-strand DNA intermediates of duck hepatitis B virus. JVirol45: 165–172.
76. Monjardino J, Fowler MJ, Montano L, Weller I, Tsiquaye KN, Zuckerman AJ, Jones DM, Thomas HC. 1982. Analysis of hepatitis virus DNA in the liver and serum of HBe antigen positive chimpanzee carriers. J Med Virol 9: 189– 199.
77. Moraleda G, Saputelli J, Aldrich CE, Averett D, Condreay L, Mason WS. 1997. Lack of effect of antiviral therapy in nondividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus. J Virol 71: 9392– 9399.
78. Murray JM, Wieland SF, Purcell RH, Chisari FV. 2005. Dynamics of hepatitis B virus clearance in chimpanzees. Proc Natl Acad Sci 102: 17780–17785.
79. Noordeen F, Vaillant A, Jilbert AR. 2013. Nucleic acid polymers inhibit duck hepatitis B virus infection in vitro. Antimicrob Agents Chemother 57: 5299–5306.
80. O’Connell AP, Urban MK, London WT. 1983. Naturally occurring infection of Pekin duck embryos by duck hepatitis B virus. Proc Natl Acad Sci 80: 1703–1706.
81. Ogston CW, Jonak GJ, Rogler CE, Astrin SM, Summers J. 1982. Cloning and structural analysis of integrated woodchuck hepatitis virus sequences from hepatocellular carcinomas of woodchucks. Cell 29: 385–394.
82. Ou JH, Laub O, Rutter WJ. 1986. Hepatitis B virus gene function: The precore region targets the core antigen to cellular membranes and causes the secretion of the e antigen. Proc Natl Acad Sci 83: 1578–1582.
83. Papatheodoris GV, Lampertico P, Manolakopoulos S, Lok A. 2010. Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: A systematic review. J Hepatol 53: 348–356.
84. Piasecki T, Harkins GW, Chrzastek K, Julian L, Martin DP, Varsani A. 2013. Avihepadnavirus diversity in parrots is comparable to that found amongst all other avian species. Virology 438: 98–105.
85. Ponzetto A, Cote PJ, Ford EC, Purcell RH, Gerin JL. 1984. Core antigen and antibody in woodchucks after infection with woodchuck hepatitis virus. J Virol 52: 70–76.
86. Prassolov A, Hohenberg H, Kalinina T, Schneider C, Cova L, Krone O, Frolich K, Will H, Sirma H. 2003. New hepatitis B virus of cranes that has an unexpected broad host range. J Virol 77: 1964–1976.
87. Prince AM, Szmuness W, Michon J, Demaille J, Diebolt G, Linhard J, Quenum C, Sankale M. 1975. A case/control study of the association between primary liver cancer and hepatitis B infection in Senegal. Int J Cancer 16: 376–383.
88. Pult I, Netter HJ, Bruns M, Prassolov A, Sirma H, Hohenberg H, Chang SF, Frolich K, Krone O, Kaleta EF, et al. 2001. Identification and analysis of a new hepadnavirus in white storks. Virology 289: 114–128.
89. Reaiche-Miller GY, Thorpe M, Low HC, Qiao Q, Scougall CA, Mason WS, Litwin S, Jilbert AR. 2013. Duck hepatitis B virus covalently closed circular DNA appears to survive hepatocyte mitosis in the growing liver. Virology 446: 357–364.
90. Rhim JA, Sandgren EP, Palmiter RD, Brinster RL. 1995. Complete reconstitution of mouse liver with xenogeneic hepatocytes. Proc Natl Acad Sci 92: 4942–4946.
91. Rigdon RH. 1961. Amyloidosis: Spontaneous occurrence in white Pekin ducks. Am J Pathol 39: 369–378.
92. Robinson WS, Greenman RL. 1974. DNA polymerase in the core of the human hepatitis B virus candidate. J Virol 13: 1231–1236.
93. Robinson WS, Clayton DA, Greenman RL. 1974. DNA of a human hepatitis B virus candidate. J Virol 14: 384–391.
94. Sabran JL, Hsu TW, Yeater C, Kaji A, Mason WS, Taylor JM. 1979. Analysis of integrated avian RNA tumor virus DNA in transformed chicken, duck and quail fibroblasts. J Virol 29: 170–178.
95. Sandgren EP, Palmiter RD, Heckel JL, Daugherty CC, Brinster RL, Degen JL. 1991. Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgene. Cell 66: 245–256.
96. Seeger C, Ganem D, Varmus HE. 1984. The cloned genome of ground squirrel hepatitis virus is infectious in the animal. Proc Natl Acad Sci 81: 5849–5852.
97. Seeger C, Ganem D, Varmus HE. 1986. Biochemical and genetic evidence for the hepatitis B virus replication strategy. Science 232: 477–484.
98. Seeger C, Marion PL, Ganem D, Varmus HE. 1987. In vitro recombinants of ground squirrel and woodchuck hepatitis viral DNAs produce infectious virus in squirrels. J Virol 61: 3241–3247.
99. Seeger C, Baldwin B, Hornbuckle WE, Yeager AE, Tennant BC, Cote P, Ferrell L, Ganem D, Varmus HE. 1991. Woodchuck hepatitis virus is a more efficient oncogenic agent than ground squirrel hepatitis virus in a common host. J Virol 65: 1673–1679.
100. 2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci 84: 1005–1009.
101. Shih CH, Li LS, Roychoudhury S, Ho MH. 1989. In vitro propagation of human hepatitis B virus in a rat hepatoma cell line. Proc Natl Acad Sci 86: 6323–6327.
102. Slagle BL, Bouchard MJ. 2015. Regulation of viral gene expression. Cold Spring Harb Perspect Med doi: 10.1101/ cshperspect.a021402.
103. Smith JK, Cywinski A, Taylor JM. 1984. Specificity of initiation of plus-strand DNA by Rous sarcoma virus. J Virol 52: 314–319.
104. Spandau DF, Lee C-H. 1988. trans-Activation of viral enhancers by the hepatitis B virus X protein. J Virol 62: 427–434.
105. Sprengel R, Kuhn C, Manso C, Will H. 1984. Cloned duck hepatitis B virus DNA is infectious in Pekin ducks. J Virol 52: 932–937.
106. Sprengel R, Kaleta EF, Will H. 1988. Isolation and characterization of a hepatitis B virus endemic in herons. J Virol 62: 932–937.
107. Standring DN, Ou JH, Masiarz FR, Rutter WJ. 1988. A signal peptide encoded within the precore region of hepatitis B virus directs the secretion of a heterogeneous population of e antigens in Xenopus oocytes. Proc Natl Acad Sci 85: 8405–8409.
108. Staprans S, Loeb DD, Ganem D. 1991. Mutations affecting hepadnavirus plus-strand DNA synthesis dissociate primer cleavage from translocation and reveal the origin of linear viral DNA. J Virol 65: 1255–1262.
109. Summers J, Mason WS. 1982. Replication of the genome of a hepatitis B–like virus by reverse transcription of an RNA intermediate. Cell 29: 403–415.
110. Summers J, O’Connell A, Millman I. 1975. Genome of hepatitis B virus: Restriction enzyme cleavage and structure of DNA extracted from Dane particles. Proc Natl Acad Sci 72: 4597–4601.
111. Summers J, Smolec JM, Snyder R. 1978. A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks. Proc Natl Acad Sci 75: 4533– 4537.
112. Summers J, Smith PM, Horwich AL. 1990. Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification. J Virol 64: 2819–2824.
113. Summers J, Jilbert AR, Yang W, Aldrich CE, Saputelli J, Litwin S, Toll E, Mason WS. 2003. Hepatocyte turnover during resolution of a transient hepadnaviral infection. Proc Natl Acad Sci 100: 11652–11659.
114. Sureau C, Romet LJ, Mullins JI, Essex M. 1986. Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA. Cell 47: 37–47.
115. Tagawa M, Omata M, Okuda K. 1986. Appearance of viral RNA transcripts in the early stage of duck hepatitis B virus infection. Virology 152: 477–482.
116. Takahashi K, Machida A, Funatsu G, Nomura M, Usuda S, Aoyagi S, Tachibana K, Miyamoto H, Imai M, Nakamura T, et al. 1983. Immunochemical structure of hepatitis B e antigen in the serum. J Immunol 130: 2903–2907.
117. Taylor JM, Illmensee R. 1975. Site on the RNA of an avian sarcoma virus at which primer is bound. J Virol 16: 553– 558.
118. Tennant BC, Gerin JL. 2001. The woodchuck model of hepatitis B virus infection. ILAR J 42: 89–102.
119. Thomas E, Yoneda M, Schiff ER. 2015. Viral hepatitis: Past and future of HBV and HDV. Cold Spring Harb Perspect Med doi: 10.1101/cshperspect.a021345.
120. Toh H, Hayashida H, Miyata T. 1983. Sequence homology between retroviral reverse transcriptase and putative polymerases of hepatitis B virus and cauliflower mosaic virus. Nature 305: 827–829.
121. Transy C, Fourel G, Robinson WS, Tiollais P, Marion PL, Buendia MA. 1992. Frequent amplification of c-myc in ground squirrel liver tumors associated with past or ongoing infection with a hepadnavirus. Proc Natl Acad Sci 89: 3874–3878.
122. Tsurimoto T, Fujiyama A, Matsubara K. 1987. Stable expression and replication of hepatitis B virus genome in an integrated state in a human hepatoma cell line transfected with the cloned viral DNA. Proc Natl Acad Sci 84: 444– 448.
123. Tuttleman JS, Pourcel C, Summers J. 1986a. Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell 47: 451–460.
124. Tuttleman JS, Pugh JC, Summers JW. 1986b. In vitro experimental infection of primary duck hepatocyte cultures with duck hepatitis B virus. J Virol 58: 17–25.
125. Twu JS, Schloemer RH. 1987. Transcriptional trans-activating function of hepatitis B virus. J Virol 61: 3448–3453.
126. Uchida T, Suzuki K, Arii M, Shikata T, Fukuda R, Tao YX. 1988. Geographical pathology of duck livers infected with duck hepatitis B virus from Chiba and Shimane in Japan and Shanghai in China. Cancer Res 48: 1319–1325.
127. Volz T, Allweiss L, MB MB, Warlich M, Lohse AW, Pollok JM, Alexandrov A, Urban S, Petersen J, Lutgehetmann M, et al. 2013. The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus. J Hepatol 58: 861–867.
128. Wang GH, Seeger C. 1992. The reverse transcriptase of hepatitis B virus acts as a protein primer for viral DNA synthesis. Cell 71: 663–670.
129. Wang GH, Seeger C. 1993. Novel mechanism for reverse transcription in hepatitis B viruses. J Virol 67: 6507– 6512.
130. Weiser B, Ganem D, Seeger C, Varmus HE. 1983. Closed circular viral DNA and asymmetrical heterogeneous forms in livers from animals infected with ground squirrel hepatitis virus. J Virol 48: 1–9.
131. Wieland S, Thimme R, Purcell RH, Chisari FV. 2004. Genomic analysis of the host response to hepatitis B virus infection. Proc Natl Acad Sci 101: 6669–6674.
132. Wieland SF, Spangenberg HC, Thimme R, Purcell RH, Chisari FV. 2004. Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees. Proc Natl Acad Sci 101: 2129–2134.
133. Wieland SF, Eustaquio A, Whitten-Bauer C, Boyd B, Chisari FV. 2005. Interferon prevents formation of replicationcompetent hepatitis B virus RNA-containing nucleocapsids. Proc Natl Acad Sci 102: 9913–9917.
134. Will H, Cattaneo R, Koch H, Darai G, Schaller H, Schellekens H, van Eerd P, Deinhardt F. 1982. Cloned HBV DNA causes hepatitis in chimpanzees. Nature 299: 740–742.
135. Will H, Reiser W, Weimer T, Pfaff E, Buscher M, Sprengel R, Cattaneo R, Schaller H. 1987. Replication strategy of human hepatitis B virus. J Virol 61: 904–911.
136. Wu GY, Zheng XJ, Yin CC, Jiang D, Zhu L, Liu Y, Wei L, Wang Y, Chen HS. 2008. Inhibition of hepatitis B virus replication by Bay 41-4109 and its association with nucleocapsid disassembly. J Chemother 20: 458–467.
137. Xu C, Yemamoto T, Zhou T, Aldrich CE, Frank K, Cullen JM, Jilbert AR, Mason WS. 2007. The liver of woodchucks infected with woodchuck hepatitis virus contains foci of virus core antigen negative hepatocytes with both altered and normal morphogy. Virology 359: 283–294.
138. Yaginuma K, Shirakata Y, Kobayashi M, Koike K. 1987. Hepatitis B virus (HBV) particles are produced in a cell culture system by transient expression of transfected HBV DNA. Proc Natl Acad Sci 84: 2678–2682.
139. Yang W, Summers J. 1995. Illegitimate replication of linear hepadnavirus DNA through nonhomologous recombination. J Virol 69: 4029–4036.
140. Yang W, Summers J. 1999. Integration of hepadnavirus DNA in infected liver: Evidence from a linear precursor. J Virol 73: 9710–9717.
141. Yang W, Mason WS, Summers J. 1996. Covalently closed circular viral DNA formed from two types of linear DNA in woodchuck hepatitis virus-infected liver. J Virol 70: 4567–4575.
142. Yim HJ, Lok AS. 2006. Natural history of chronic hepatitis B virus infection: What we knew in 1981 and what we know in 2005. Hepatology 43: S173–S181.
143. Zhang Z, Torii N, Hu Z, Jacob J, Liang TJ. 2001. X-deficient woodchuck hepatitis virus mutants behave like attenuated viruses and induce protective immunity in vivo. J Clin Invest 108: 1523–1531.
144. Zheng Y, Chen WL, Louie SG, Yen TS, Ou JH. 2007. Hepatitis B virus promotes hepatocarcinogenesis in transgenic mice. Hepatology 45: 16–21.
145. Zoulim F, Durantel D. 2015. Antiviral therapies and prospects for a cure of chronic hepatitis B. Cold Spring Harb Perspect Med doi: 10.1101/cshperspect.a021501.
146. Zoulim F, Seeger C. 1994. Woodchuck hepatitis virus X protein is required for viral infection in vivo. J Virol 68: 2026–2030.